In CRC cell models, knocking down NNT-AS1 resulted in significantly reduced proliferation, migration, invasion in vitro and in vivo through downregulating the MAPK/Erk signaling pathway and inhibiting EMT. This evidence concerns the gene NNT and colorectal carcinoma.